Startseite The crystal structure of (E)-N′-(1-(3-chloro-4-fluorophenyl) ethylidene)-2-hydroxybenzohydrazide, C15H12ClFN2O2
Artikel Open Access

The crystal structure of (E)-N′-(1-(3-chloro-4-fluorophenyl) ethylidene)-2-hydroxybenzohydrazide, C15H12ClFN2O2

  • Xifeng Yan , Shibin Zhong ORCID logo EMAIL logo und Hong Zhang
Veröffentlicht/Copyright: 25. Oktober 2019

Abstract

C15H12ClFN2O2, monoclinic, P21/c (no. 14), a = 13.9210(13) Å, b = 13.2329(15) Å, c = 18.7191(19) Å, β = 126.250(2)°, V = 2780.9(5) Å3, Z = 8, Rgt(F) = 0.0499, wRref(F2) = 0.1420, T = 293(2) K.

CCDC no.: 1958013

The asymmetric unit of the molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless block
Size:0.20 × 0.15 × 0.12 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.29 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω
θmax, completeness:27.5°, >99%
N(hkl)measured, N(hkl)unique, Rint:19612, 6361, 0.084
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 4081
N(param)refined:381
Programs:Bruker [1], SHELX [2]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C11.0604(2)0.1301(2)0.87188(19)0.0507(7)
H11.05930.19980.86510.061*
C21.0925(2)0.0916(2)0.95159(19)0.0513(7)
H21.11380.13460.99820.062*
C31.0924(2)−0.0121(2)0.96110(19)0.0514(7)
H31.1128−0.03911.01430.062*
C41.0626(2)−0.0756(2)0.89280(18)0.0513(7)
H41.0640−0.14510.90040.062*
C51.0304(2)−0.0370(2)0.81273(18)0.0497(7)
C61.0294(2)0.06784(19)0.80076(18)0.0504(7)
C70.9952(2)0.1184(2)0.71837(18)0.0502(7)
C80.8638(2)0.0364(2)0.49458(19)0.0525(8)
C90.8362(2)0.0955(2)0.41578(18)0.0505(7)
C100.8011(2)0.0419(2)0.33914(18)0.0510(7)
H100.8037−0.02830.34090.061*
C110.7634(2)0.08997(19)0.26193(18)0.0494(7)
C120.7603(2)0.1938(2)0.25817(19)0.0514(7)
C130.7950(2)0.2521(2)0.33139(18)0.0533(7)
H130.79330.32230.32870.064*
C140.8322(2)0.20163(19)0.40882(19)0.0538(8)
H140.85570.23970.45850.065*
C150.8372(2)−0.07834(19)0.49145(18)0.0527(7)
H15A0.8685−0.10160.55000.079*
H15B0.8741−0.11500.46930.079*
H15C0.7527−0.08920.45310.079*
C160.5796(2)0.14467(19)0.87763(18)0.0494(7)
H160.57650.07480.87140.059*
C170.6282(2)0.18537(19)0.96035(19)0.0512(7)
H170.65810.14371.00930.061*
C180.6317(2)0.28978(19)0.96899(18)0.0487(7)
H180.66530.31841.02440.058*
C190.5861(2)0.3513(2)0.89660(18)0.0511(7)
H190.58710.42100.90320.061*
C200.5385(2)0.31049(19)0.81365(18)0.0483(7)
C210.5347(2)0.20525(19)0.80263(18)0.0489(7)
C220.4876(2)0.1529(2)0.71805(18)0.0496(7)
C230.3919(2)0.2306(2)0.50090(19)0.0532(8)
C240.3444(2)0.16985(19)0.41862(18)0.0500(7)
C250.2960(2)0.2210(2)0.33834(17)0.0510(7)
H250.28880.29090.33700.061*
C260.2592(2)0.17142(19)0.26227(18)0.0504(7)
C270.2680(2)0.06791(19)0.26216(18)0.0497(7)
C280.3124(2)0.0105(2)0.33861(18)0.0509(7)
H280.3163−0.05970.33820.061*
C290.3502(2)0.06377(19)0.41518(18)0.0510(7)
H290.38100.02740.46700.061*
C300.4129(2)0.34686(19)0.50572(18)0.0559(8)
H30A0.36330.38040.51830.084*
H30B0.39320.37030.45000.084*
H30C0.49500.36150.55180.084*
Cl10.71888(6)0.02090(5)0.16886(5)0.0551(2)
Cl20.20314(5)0.23827(5)0.16556(4)0.0528(2)
F10.72159(12)0.24023(11)0.18107(10)0.0539(4)
F20.23185(12)0.01976(11)0.18642(10)0.0520(4)
N10.45966(17)0.21313(16)0.64992(15)0.0488(6)
H1A0.46940.27720.65900.059*
N20.41626(17)0.17763(16)0.56630(15)0.0497(6)
N30.95095(17)0.05715(16)0.64765(15)0.0493(6)
H3A0.9464−0.00640.65470.059*
N40.91240(18)0.09048(16)0.56430(15)0.0519(6)
O11.00053(14)−0.09903(13)0.74459(12)0.0511(5)
H1E1.0059−0.16800.76250.077*
O21.00823(14)0.21007(13)0.71545(12)0.0520(5)
O30.49501(14)0.37106(12)0.74203(12)0.0500(5)
H3E0.50340.44050.75960.075*
O40.47437(15)0.06042(13)0.71121(12)0.0533(5)

Source of material

A mixture of 2-hydroxy-benzoic acid hydrazide (1 mmol, 152.2 mg) and 1-(3-chloro-4-fluoro-phenyl)-ethanone (1 mmol, 172.6 mg) in anhydrous ethanol (25 mL) was kept under reflux conditions (351 K) for 3 h. The solvent was removed under reduced pressure and the solid product was recrystallized from 15 mL of anhydrous ethanol. After 4 days, colourless block-shaped crystals were obtained.

Experimental details

Coordinates of hydrogen atoms were refined without any constraints or restraints. The Uiso values were set to be 1.5Ueq of the carrier atom for methyl H atoms and 1.2Ueq for the remaining H atoms.

Comment

In recent years, Schiff bases as one of the important synthetic intermediates have attracted more and more attention due to the wide applications in the fields of coordination chemistry, biochemistry, pharmacy, nanotechnology, and photochemistry [3], [4], [5], [6], [7], [8], [9], [10]. From the structural point of view, o-hydroxy Schiff bases are attractive because of their intramolecular H-bond, and thus have been extensively investigated and reported [11], [12], [13], [14], [15], [16], [17]. In addition, the heteroatoms (such as N, F, Cl, Br, S) can act as hydrogen bonding acceptors for bioactive molecules in order to exhibit higher biological activity [18], [19]. But, the unsymmetrical o-hydroxy Schiff bases containing heteroatoms especial of F and Cl in one molecule are less investigated. Herein, in order to search for new o-hydroxy Schiff bases containing F and Cl heteroatoms, we have undertaken the synthesis and single crystal structure determination of the title compound (cf. the figure).

In the title compound, there are two crystallographically independent molecules in the asymmetric unit, which have very similar conformations. Compared with those of closely related structure, such a structural feature is uncommon [15]. The bond lengths and angles are in the expected ranges which fit with those of related compounds in literature [11], [12], [13], [14], [15], [16], [17]. The C=N double bond lengths in the independent molecule are 1.277(3) Å (C8=N4) and 1.271(4) Å (C23=N2), respectively, exhibiting the double bond character. The aromatic rings form dihedral angles of 3.9° and 4.2° in the two independent molecules. In the crystal structure, the molecules are linked into double infinite chains by O—H⋯O hydrogen bonds. There also exist intramolecular N—H⋯O hydrogen bonds, which further consolidate the crystal packing.

Acknowledgements

This work was financially supported by East China University of Technology.

References

1. Bruker. APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, WI, USA (2008).Suche in Google Scholar

2. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

3. Zhang, L. S.; Chen, Q.; Hou, G. G.; Zhao, W.; Hou, Y.: Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation. J. Enzyme Inhib. Med. Chem. 34 (2019) 264–271.10.1080/14756366.2018.1501042Suche in Google Scholar PubMed PubMed Central

4. Pu, X.: The crystal structure of (E)-4-chloro-2-(((5-methylpyridin-2-yl)imino)methyl)phenol, C13H11ClN2O. Z. Kristallogr. NCS 233 (2018) 253–254.10.1515/ncrs-2017-0254Suche in Google Scholar

5. Chang, F. F.; Zhang, L.; Zhao, P. C.; Huang, W.: Transmetalation for flexible pendant-armed Schiff-base macrocyclic complexes influenced by halide effects. Inorg. Chem. 57 (2018) 1438–1448.10.1021/acs.inorgchem.7b02835Suche in Google Scholar PubMed

6. Aboura, W.; Benabdallah, T.; Zhang, F.; Therrien, B.: Alkoxylation of the imine carbon atom of a Schiff-base ligand upon coordination to arene ruthenium. Inorg. Chim. Acta 483 (2018) 93–97.10.1016/j.ica.2018.07.025Suche in Google Scholar

7. Kadwa, E.; Bala, M. D.; Friedrich, H. B.: Base metal Schiff base complexes applied as catalysts for the oxidation of n-octane. Inorg. Chim. Acta 463 (2017) 112–117.10.1016/j.ica.2017.04.032Suche in Google Scholar

8. Shanty, A.; Philip, J.; Sneha, E.; Kurup, M.; Balachandran, S.; Mohanan, P.: Synthesis, characterization and biological studies of Schiff bases derived from heterocyclic moiety. Bioorg. Chem. 70 (2017) 67–73.10.1016/j.bioorg.2016.11.009Suche in Google Scholar PubMed

9. Abu-Dief, A. M.; Mohamed, I. M. A.: A review on versatile applications of transition metal complexes incorporating Schiff bases. Beni-suef Univ. J. Basic Appl. Sci. 4 (2015) 119–133.10.1016/j.bjbas.2015.05.004Suche in Google Scholar PubMed PubMed Central

10. Li, P.; Niu, M.-J.; Hong, M.; Cheng, S.; Dou, J.-M.: Effect of structure and composition of nickel(II) complexes with salicylidene Schiff base ligands on their DNA/protein interaction and cytotoxicity. J. Inorg. Biochem. 137 (2014) 101–108.10.1016/j.jinorgbio.2014.04.005Suche in Google Scholar PubMed

11. Fan, C. G.; Song, M. Z.: (E)-N′-[1-(4-Bromophenyl)ethylidene]-2-hydroxybenzohydrazide. Acta Crystallogr. E65 (2009) o2792.10.1107/S1600536809042081Suche in Google Scholar PubMed PubMed Central

12. Li, M. L.; Huang, X.; Feng, R. K.: (E)-N′-[1-(4-Chlorophenyl)ethylidene]-2-hydroxybenzohydrazide. Acta Crystallogr. E65 (2009) o369.10.1107/S1600536809002311Suche in Google Scholar PubMed PubMed Central

13. Yue, S. Y.; Lu, J. F.: N′-[1-(2-Hydroxyphenyl)ethylidene]-2-methoxybenzohydrazide. Acta Crystallogr. E66 (2010) o1550.10.1107/S1600536810020477Suche in Google Scholar PubMed PubMed Central

14. Qiu, X. Y.; Luo, Q. Y.; Yang, S. L.; Liu, W. S.: (E)-2-Hydroxy-N′-[1-(4-methoxyphenyl)-ethylidene]benzohydrazide. Acta Crystallogr. E62 (2006) o4291–o4292.10.1107/S1600536806029345Suche in Google Scholar

15. Patra, D.; Biswas, N.; Kumari, B.; Das, P.; Sepay, N.; Chatterjee, S.; Drew, M. G. B.; Ghosh, T.: A family of mixed-ligand oxidovanadium(V) complexes with aroylhydrazone ligands: a combined experimental and computational study on the electronic effects of para substituents of hydrazone ligands on the electronic properties, DNA binding and nuclease activities. RSC Adv. 5 (2015) 92456–92472.10.1039/C5RA17844DSuche in Google Scholar

16. Shan, S.; Tian, Y. L.; Wang, S. H.; Wang, W. L.; Xu, Y. L.: (E)-N′-[1-(4-Aminophenyl)ethylidene]benzohydrazide. Acta Crystallogr. E64 (2008) o1363.10.1107/S1600536808019004Suche in Google Scholar PubMed PubMed Central

17. Shi, X. F.; Xing, Z. F.: (E)-N′-[1-(4-Aminophenyl)ethylidene]-2-hydroxybenzohydrazide methanol solvate. Acta Crystallogr. E63 (2007) o4771.10.1107/S1600536807058552Suche in Google Scholar

18. Yao, B. R.; Li, N.; Wang, C. H.; Hou, G. G.; Meng, Q. G.; Yan, K.: Novel asymmetric 3,5-bis(arylidene)piperidin-4-one derivatives: synthesis, crystal structures and cytotoxicity. Acta Crystallogr. C74 (2018) 659–665.10.1107/S2053229618006605Suche in Google Scholar PubMed

19. Li, N.; Bai, X. Y.; Zhang, L. S.; Hou, Y.: Synthesis, crystal structures and anti-inflammatory activity of four 3,5-bis(arylidene)-N-benzenesulfonyl-4-piperidone derivatives. Acta Crystallogr. C74 (2018) 1171–1179.10.1107/S2053229618013232Suche in Google Scholar PubMed

Received: 2019-08-07
Accepted: 2019-10-08
Published Online: 2019-10-25
Published in Print: 2020-02-25

© 2019 Xifeng Yan et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Artikel in diesem Heft

  1. Frontmatter
  2. Synthesis and crystal structure of bis{5-fluorine-2-(((4-(1-(methoxy-imino)ethyl)phenyl) imino)methyl)phenolato-κ2N,O}copper(II), C32H28CuF2N4O4
  3. Redetermination of the crystal structure of N′-(3-ethoxy-2-hydroxybenzylidene)-4-fluorobenzohydrazide monohydrate, C16H17FN2O4
  4. The crystal structure of (E)-N′-(1-(3-chloro-4-fluorophenyl) ethylidene)-2-hydroxybenzohydrazide, C15H12ClFN2O2
  5. Crystal structure of (E)-N-[4-(1H)-imidazolyl phenyl]-(2-methylphenyl)methanimine, C17H15N3
  6. The crystal structure of 1-benzyl-4-(2-(phenylethynyl)phenyl)-1H-1,2,3-triazole, C23H17N3
  7. Crystal structure of catena-poly[{μ2-1,5-bis(diphenylphosphanyl)pentane-κ2P:P′}dichloridocadmium(II)], C29H30CdCl2P2
  8. Crystal structure of methyl (E)-N2-((3-methylquinolin-8-yl)sulfonyl)-Nω-nitro-L-argininate - ethanol (1/1), C19H28N6O7S
  9. The crystal structure of trans-carbonyl-(diphenylcyclohexyl-phosphine-κP)iodidomethyl-(2-oxopyridin-1(2H)-olato-κ2O,O′)rhodium(III), C25H28INO3PRh
  10. Crystal structure of N-(amino(pyrazin-2-yl)methylene)-6-methylpyridin-1-ium-3-carbohydrazonate-κ3O,N,N′)-(dinitrato-κ1O)zinc(II), C12H12N8O7Zn
  11. The crystal structure of dichlorido-(tris(2-benzimidazolylmethyl)amine-κ4N,N′,N′′,N′′′)chromium(III) chloride — methanol (1/3), CrC27H33Cl3N7O3
  12. Crystal structure of catena-poly[aqua(μ4-piperazine-1,4-bis(2-hydroxypropanesulfonato-κ8O,O′:O′,N:N′,O′′:O′′,O′′′))silver(I)], C10H24Ag2N2O10S2
  13. Crystal structure of bis(μ3-oxido)-bis(μ2–2,3,4,5-tetrafluorobenzoato-κ2O:O′)-bis(2,3,4,5-tetrafluorobenzoato-κO)-oktakis(3-chlorobenzyl-κC)tetratin(IV), C84H52Cl8F16O10Sn4
  14. Crystal structure of (E)-1-{4-[(4-fluoro-2-hydroxybenzylidene)amino]phenyl}ethanone O-methyl oxime, C16H15FN2O2
  15. Crystal structure of catena-[(bis(O,O′-diethyl dithiophosphato-S,S′)-μ2-1,2-bis(3-pyridylmethylene)hydrazine-N,N′)zinc(II)], {C20H30N4O4P2S4Zn}n
  16. Crystal structure of methyl 2-(4-(3-iodopyrazolo[1,5-a]pyrimidin-6-yl)phenyl)acetate, C15H12IN3O2
  17. Crystal structure of hexacarbonyl-(μ2-methanoato-k2O:O′)-(μ2–bis(di-p-tolylphosphino)cyclohexylamine-κ2P:P′)dirhenium(I), C42H45NO8P2Re2
  18. The cocrystal structure of 1′-hydroxy-1H,1′H-[5,5′-bitetrazol]-1-olate and 1,10-phenanthrolin-1-ium, C14H10N10O2
  19. The crystal structure of 1-benzyl-2-((4-(tert-butyl)phenyl)ethynyl)pyridin-1-ium bromide,C24H24BrN
  20. Crystal structure of (5,5′-bitetrazole-1,1′-diolate)-bis(1,10-phenanthroline)-copper(II), C26H16CuN12O2
  21. Crystal structure of bis(ammonium) diaqua-tetrakis(4-hydroxybenzoato)-manganese(II) tetrahydrate, [NH4]2[C28H24MnO14] ⋅ 4(H2O)
  22. The crystal structure of 3-chloro-1-hydrazino-2,4,6-trinitrobenzene, C6H4ClN5O6
  23. Crystal structure of catena-[(μ2-pyrazine-κ2N:N′)-bis(O,O′-di-ethyldithiophosphato-κ2S,S′)cadmium(II)], {C12H24CdN2O4P2S4}n
  24. Crystal structure of catena-poly[(μ2-pyrazine-N,N′)-bis(O,O′-di-isopropyldithiophosphato-S,S′)cadmium(II) acetonitrile di-solvate], [C16H32CdN2O4P2S4⋅2(C2H3N)]n
  25. Crystal structure of catena-poly{(μ2-N1,N2-bis[(pyridin-4-yl)methyl]ethanediamide-κ2N:N′)-bis(O,O′-di-isopropyldithiophosphato-κ1S)zinc(II)} — acetonitrile (1/1), C26H42N4O6P2S4Zn⋅C2H3N
  26. Crystal structure of tetraqua-bis(4-(hydroxymethyl)benzoato-κO)cobalt(II), C16H22O10Co
  27. Crystal structure of catena-[(bis(O,O′-diethyl dithiophosphato-S,S′)-μ2-1,2-bis(4-pyridylmethylene)hydrazine-N,N′)cadmium(II)], {C20H30CdN4O4P2S4}n
  28. Crystal structure of catena-poly[(μ2-1,2-bis(3-pyridylmethylene)hydrazine-κ2N:N′)-bis(O,O′-dimethyl dithiophosphato-κ2-S,S′)cadmium(II)], {C16H22CdN4O4P2S4}n
  29. Crystal structure of catena-poly[(bis(O,O′-diethyl dithiophosphato-κ2S,S′)-μ2-1,2-bis(3-pyridylmethylene)hydrazine-κ2N:N′)cadmium(II)], {C20H30CdN4O4P2S4}n
  30. The crystal structure of catena-poly[(E)-2-(((5-((trimethylstannyl)thio)-1,3,4-thiadiazol-2-yl)imino)methyl)phenol], C12H15N3OS2Sn
  31. Crystal structure of dichlorido(N-o-tolyl-1,1-di-p-tolylphosphanamine–κ1P)-(methoxydi-p-tolylphosphane-κ1P)palladium(II), C36H39Cl2NOP2Pd
  32. The crystal structure of the triclinic polymorph of hexameric (trimethylsilyl)methyllithium, C24H66Li6Si6
  33. Crystal structure of bis(hydroxydi(pyridin-2-yl)methanolato-κ3N,N′O)cobalt(III) 7,7,8,8-tetracyanoquinodimethane, C34H22CoN8O4
  34. Synthesis and crystal structure of benzyl 5-oxo-5-phenyl-2-(quinolin-2-yl)pentanoate, C27H23NO3
  35. Crystal structure of 5,5-dimethyl-3-oxocyclohex-1-en-1-yl 4-(2,2-dichloroacetyl)-3,4-dihydro-2 H-benzo[b][1,4]oxazine-7-carboxylate, C19H19Cl2NO5
  36. Crystal structure of dipentyl 2,5-dihydroxycyclohexa-1,4-diene-1,4-dicarboxylate, C18H28O6
  37. The crystal structure of catena-poly[diaqua-(μ4-5-(benzo[d]thiazol-2-yl)benzene-1,3-dicarboxylate-κ4O,O′:O′′,O′′′)-(μ4-5-(benzo[d]thiazol-2-yl)benzene-1,3-dicarboxylate-κ4O,O′:O′′,O′′′)dicadmium(II)], C30H18Cd2N2O10S2
  38. Crystal structure of 2,7-diiodo-1,3,6,8-tetramethyl-bis(difluoroboron)-1,2-bis((1H-pyrrol-2-yl)methylene)hydrazine, C14H14B2F4I2N4
  39. A dinuclear Eu(III) complex in the crystal structure of dodecaaqua-bis(μ2-4-(1H-tetrazol-5-yl)benzoato-κ2O:O′) bis(5-(4-carboxylatophenyl)tetrazol-1-ide) tetrahydrate, C32H50Eu2N16O24
  40. Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one, C24H18F2N2O3S
  41. Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-acetamidophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one-methanol-hydrate (2/1/1), C53H50F2N6O10S2
  42. Crystal structure of 4-dimethylamino-pyridin-1-ium uracil-1-acetate, C13H16N4O4
  43. Crystal structure of dimethylammonium 5-fluorouracil-1-acetate, C8H12N3O4F
  44. Crystal structure of bis(N′-((5-(ethoxycarbonyl)-1H-pyrrol-2-yl)methylene)-N-ethylcarbamohydrazonothioato-κ2N,O)nickel(II), C22H30N8O4S2Ni
  45. Crystal structure of chlorido-(η5-pentamethylcyclopentadienyl)-((bis-pyrazol-1-yl)methane-κ2N,N′) rhodium(III) hexafluorophosphate. (C17H23ClN4RhF6P)
  46. The crystal structure of 5-(benzofuran-2-carbonyl)-N-cyclohexyl-5,6-dihydrophenanthridine-6-carboxamide, C29H26N2O3
  47. The crystal structure of 2-oxo-2H-chromen-4-yl acetate, C11H8O4
  48. The crystal structure of 2-nitroisophthalic acid, C8H5NO6
  49. Crystal structure of 3-fluoro-9-methoxy-4b,5,14,15-tetrahydro-6H-isoquinolino [2′,1′:1,6]pyrazino[2,3-b]quinoxaline, C19H17FN4O
  50. Crystal structure of (4-fluorobenzyl-κC)(bis(2-hydroxyethyl) carbamodithioato-κ2S,S′)(2,2′-imino-diethanolato-κ3N,O,O′)tin(IV), C16H25FN2O4S2Sn
  51. Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-bromophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C25H18BrF3N2O3S
  52. Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-chlorophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C25H18ClF3N2O3S
  53. The crystal structure of 3-((1R,2S)-1-methylpyrrolidin-1-ium-2-yl)pyridin-1-ium tetrachloridomanganate(II), C10H16Cl4MnN2
  54. The crystal structure of 3-carboxy-5-methylpyridin-1-ium-2-carboxylate, C8H7NO4
  55. Crystal structure of bis(3-methoxy-N-(1-(pyridin-2-yl)ethylidene)benzohydrazonato κ3O,N,N′)zinc(II), C30H28N6O4Zn
  56. Crystal structure of dichlorido-(4,4′-dichloro-2,2′-bipyridine-κ2N,N′)platinum(II) — acetone (1/1), C13H12Cl4N2PtO
  57. Crystal structure of diethyl 6,12-bis(4-fluorophenyl)-2,10-dimethoxy-3,9-diphenyl-3,9-diazatetracyclo[6.4.0.02,7.04,11]dodecane-1,5-dicarboxylate, C42H42F2N2O6
  58. Synthesis and crystal structure of (1E,3E)-2-hydroxy-5-methylisophthalaldehyde O,O-di(2-((((E)-(2-hydroxynaphthalen-1-yl)methylene)amino)oxy)ethyl) dioxime, C35H32N4O7
  59. The crystal structure of 2-phenyl-4,6-bis(prop-2-yn-1-yloxy)-1,3,5-triazine, C15H11N3O2
  60. Crystal structure of 7-(2-{4-[(4-bromophenyl)methyl]piperazin-1-yl}ethoxy)-2H-chromen-2-one, C22H23BrN2O3
  61. Crystal structure of bis-[N-(3-ethyl-1-pyrazin-2-yl-ethylidene)-3-bromo-benzoic acid-hydrazonato-κ3O,N,N′)]-cadmium(II), C30H28N8O2Br2Cd
  62. Crystal structure of 6-(4-fluorophenyl)-4-methoxy-2H-pyran-2-one, C12H9FO3
  63. Crystal structure of 3-methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)butanoic acid, C14H18O4
  64. The crystal structure of 3-bromo-6-methoxy-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, C13H19BBrNO3
  65. The crystal structure of 6-methyl-3,20-dioxo-19-norpregna-4,6-dien-17-yl acetate–2,4-dihydroxybenzoic acid (1/1), C30H36O8
  66. The crystal structure of (5-chloro-2-hydroxy-N-(4-methoxy-2-oxidobenzylidene)benzohydrazonato-κ3N,O,O′)-(pyridine-κ1N)copper(II), C20H16ClCuN3O4
  67. Crystal structure of (E)-2-cyano-N′-(1-(3-ethylpyrazin-2-yl)ethylidene)acetohydrazide, C11H3N5O
  68. Crystal structure of (2,7-dihexyl-9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphane), C51H56OP2
  69. Crystal structure of 5-((bis(pyridin-2-ylmethyl)amino)methyl)quinolin-8-ol, C22H20N4O
  70. Crystal structure of 3-(2-(5-(4-fluorophenyl)-3-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl)thiazol-4-yl)-2H-chromen-2-one, C28H20FN3O2S
  71. The crystal structure of [(tetra-μ2-2,6-difluorobenzoato-κ2O:O′)-bis-(2,6-difluorobenzoato-κ2O:O′)-bis-(1,10-phenanthroline-κ2N:N′)]dierbium(III) C66H34N4O12F12Er2
  72. Crystal structure of bis(3-chloro-N-(1-(pyrazin-2-yl)ethylidene)benzohydrazonato-k3N,N′,O)nickel(II), C26H20N8O2Cl2Ni
  73. Crystal structure of (E)-3-(3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-one, C27H21N5O
  74. Crystal structure of (E)-N′-((4-aminophenyl)sulfonyl)-N,N-dimethylformimidamide, C9H13N3O2S
  75. Crystal structure of η6-p-cymene-iodido-(N-isopropyl-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) hexafluorophosphate(V), C19H26IN2F6Ru
  76. Crystal structure of 6-iodo-3-phenyl-2-propylquinazolin-4(3H)-one, C17H15IN2O
  77. Low temperature redetermination of the crystal structure of catena-poly[[tri-4-fluorobenzyltin(IV)]μ2-pyridine-4-carboxylato-κ2N:O], {C27H22F3NO2Sn}n
  78. Crystal structure of bis(2-propyl-1H-benzo[d]imidazol-3-ium) tetrachloridozincate(II), C10H13Cl4N2Zn
  79. The crystal structure of (Z)-3-hydrazono-5-nitroindolin-2-one – dimethyl sulfoxide (1/1), C8H6N4O3
  80. Crystal structure of bis-[N-(1-pyrazin-2-yl-ethylidene)-cyanoacetic acid-hydrazonato-κ3O,N,N′)]-zinc(II), C18H16N10O2Zn
  81. Crystal structure and photochromism of 1-(2,5-dimethyl-3-thienyl)-2-[2-methyl-5-(benzaldoxime)-3-thienyl] perfluorocyclopentene, C23H17F6NOS2
Heruntergeladen am 17.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0571/html?lang=de
Button zum nach oben scrollen